Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.

Gastroenterology 2007 Nov 24;133(5):1554-68. Epub 2007 Oct 24.

CNRS UMR5203, Montpellier, France.

Background & Aims: Aberrant activation of the beta-catenin/Tcf-4 transcriptional complex represents an initiating event for colorectal carcinogenesis, shifting the balance from differentiation toward proliferation in colonic crypts. Here, we assessed whether endogenous progastrin, encoded by a target gene of this complex, was in turn able to regulate beta-catenin/Tcf-4 activity in adenomatous polyposis coli (APC)-mutated cells, and we analyzed the impact of topical progastrin depletion on intestinal tumor growth in vivo.

Methods: Stable or transient RNA silencing of the GAST gene was induced in human tumor cells and in mice carrying a heterozygous Apc mutation (APCDelta14), which overexpress progastrin but not amidated or glycine-extended gastrin.

Results: Depletion of endogenous progastrin production strongly decreased intestinal tumor growth in vivo through a marked inhibition of constitutive beta-catenin/Tcf-4 activity in tumor cells. This effect was mediated by the de novo expression of the inhibitor of beta-catenin and Tcf-4 (ICAT), resulting from a down-regulation of integrin-linked kinase in progastrin-depleted cells. Accordingly, ICAT down-regulation was correlated with progastrin overexpression and Tcf-4 target gene activation in human colorectal tumors, and ICAT repression was detected in the colon epithelium of tumor-prone, progastrin-overexpressing mice. In APCDelta14 mice, small interfering RNA-mediated progastrin depletion not only reduced intestinal tumor size and numbers, but also increased goblet cell lineage differentiation and cell apoptosis in the remaining adenomas.

Conclusions: Thus, depletion of endogenous progastrin inhibits the tumorigenicity of APC-mutated colorectal cancer cells in vivo by promoting ICAT expression, thereby counteracting Tcf-4 activity. Progastrin targeting strategies should provide an exciting prospect for the differentiation therapy of colorectal cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2007.08.023DOI Listing
November 2007

Publication Analysis

Top Keywords

intestinal tumor
12
endogenous progastrin
12
progastrin
9
tumor growth
8
target gene
8
beta-catenin/tcf-4 activity
8
depletion endogenous
8
colorectal cancer
8
icat down-regulation
8
tumor cells
8
progastrin targeting
8
progastrin depletion
8
cells
5
tumor
5
inhibitor beta-catenin
4
mediated novo
4
cells mediated
4
novo expression
4
expression inhibitor
4
beta-catenin tcf-4
4

Altmetric Statistics

Similar Publications